Výsledky vyhledávání

Chidamide induces EBV lytic infection and synergistically with tenofovir eliminate EBV-positive Burkitt lymphoma and inhibit EBV DNA replication

Autor: Linyan Xu, Meng Zhang, Dongyun Tu, Ziyi Lu, Tianyi Lu, Dongshen Ma, Yi Zhou, Shuo Zhang, Yuhan Ma, Dongmei Yan, Xiangmin Wang, Wei Sang

The authors have requested that this preprint be removed from Research Square.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::58c4a09c96911db1df135faca91e1fbb
https://doi.org/10.21203/rs.3.rs-1952984/v1

Zobrazit plný text záznamu

l ‐Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein−Barr virus‐positive Burkitt lymphoma

Autor: Wei Sang, Dongyun Tu, Meng Zhang, Yuanyuan Qin, Wenjing Yin, Xuguang Song, Cai Sun, Dongmei Yan, Xiangmin Wang, Lingyu Zeng, Zhenyu Li, Kailin Xu, Linyan Xu

Publikováno v: Journal of Biochemical and Molecular Toxicology. 36

Burkitt lymphoma (BL) is an aggressive Epstein-Barr virus (EBV)-driven B-cell lymphoma characterized by the translocation and rearrangement of the c-Myc proto-oncogene. High-intensity multidrug chemotherapy regimens have a limited effect on the survi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b29e0a80a33502be3a99cff419165ee
https://doi.org/10.1002/jbt.23117

Zobrazit plný text záznamu

The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma

Autor: Meng Zhang, Dongyun Tu, Cai Sun, Kailin Xu, Wei Sang, Xiangmin Wang, Yuanyuan Qin, Mengdi Liu, Jun Jiao, Linyan Xu, Xuguang Song, Feng Zhu, Dongmei Yan

Publikováno v: Anti-cancer agents in medicinal chemistry. 22(8)

Background: Extranodal natural killer/T cell lymphoma (ENKTL) is an aggressive malignant non- Hodgkin's lymphoma (NHL) with a poor prognosis. Therefore, novel therapeutic biomarkers and agents must be identified for the same. KAT5 inhibitor, NU 9056,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3757583bc2e7a34a16c6b15ef4dccb1
https://pubmed.ncbi.nlm.nih.gov/34503423

Zobrazit plný text záznamu

Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era

Autor: Ziyuan Shen, Shanlin Nie, Yuanyuan Qin, Dongyun Tu, Wei Sang, Xuguang Song, Zhenyu Li, Yuhan Ma, Yingliang Jin, Kailin Xu, Cai Sun, Linyan Xu, Zhenzhen Bian, Hang Zhou, Dongmei Yan

Publikováno v: International journal of hematology. 114(2)

Vascular endothelial growth factor affects the invasiveness of solid tumors by regulating angiogenesis. However, it is not clear whether VEGF could be used to predict the prognosis of DLBCL in the era of rituximab-based immunotherapy. We conducted a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::521b517e2348bb1bb42504a4fc21adff
https://pubmed.ncbi.nlm.nih.gov/33893987

Zobrazit plný text záznamu